ArticleGene therapy2013

Expression of HSV-1 receptors in EBV-associated lymphoproliferative disease determines susceptibility to oncolytic HSV.

P-Y Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.